Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 442-446, February 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craig, R. W.
Right arrow Articles by Bloch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craig, R. W.
Right arrow Articles by Bloch, A.

Early Decline in c-myb Oncogene Expression in the Differentiation of Human Myeloblastic Leukemia (ML-1) Cells Induced with 12-O-Tetradecanoylphorbol-13-acetate1

Ruth W. Craig and Alexander Bloch

Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, New York 14263

The relationship of oncogene expression to proliferation and differentiation has been examined in a line of human myeloblastic leukemia (ML-1) cells. Proliferating leukemic cells were found to express a 4.3-kilobase cellular homologue (c-myb) of the transforming sequence of avian myeloblastosis virus. A rapid decline in the expression of this transcript was seen in cells induced to differentiate with 12-O-tetradecanoylphorbol-13-acetate. The level of c-myb RNA was decreased by >50% as early as 3 hr after 12-O-tetradecanoylphorbol-13-acetate exposure, and at 8 to 72 hr the reduction was ≥4-fold. Subsequent to the decrease in oncogene expression at 3 hr, DNA synthesis began to decline; by 24 hr, cell proliferation had ceased. At this time, monocyte-and marcrophage-like cells were beginning to emerge. These findings demonstrate that c-myb is expressed during ML-1 cell proliferation and declines prior to the loss of DNA synthesis that accompanies the differentiation process.

1 Supported by Grant CA12585 from the National Cancer Institute.

Received 8/15/83. Accepted 10/25/83.




This article has been cited by other articles:


Home page
Cell Growth Differ.Home page
H. He, X. Wang, M. Gorospe, N. J. Holbrook, and M. A. Trush
Phorbol Ester-induced Mononuclear Cell Differentiation Is Blocked by the Mitogen-activated Protein Kinase Kinase (MEK) Inhibitor PD98059
Cell Growth Differ., May 1, 1999; 10(5): 307 - 315.
[Abstract] [Full Text]


Home page
ScienceHome page
T. Bender, C. Thompson, and W. Kuehl
Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation
Science, September 18, 1987; 237(4821): 1473 - 1476.
[Abstract] [PDF]


Home page
ScienceHome page
C Barletta, P. Pelicci, L. Kenyon, S. Smith, and R Dalla-Favera
Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas
Science, February 27, 1987; 235(4792): 1064 - 1067.
[Abstract] [PDF]


Home page
ScienceHome page
W. Hsiao, S Gattoni-Celli, and I. Weinstein
Oncogene-induced transformation of C3H 10T1/2 cells is enhanced by tumor promoters
Science, November 2, 1984; 226(4674): 552 - 555.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.